4//SEC Filing
Louie Ngar Yee 4
Accession 0001127602-24-013490
CIK 0001878313other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:33 PM ET
Size
7.0 KB
Accession
0001127602-24-013490
Insider Transaction Report
Form 4
Louie Ngar Yee
Director
Transactions
- Purchase
Common Stock
2024-04-25$2.03/sh+19,665$39,920→ 1,167,189 total - Purchase
Warrants
2024-04-25$2.26/sh+19,665$44,443→ 19,665 totalExercise: $2.26From: 2024-10-25Exp: 2029-10-25→ Common Stock (19,665 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024.
- [F2]The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913264
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:33 PM ET
- Size
- 7.0 KB